These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1593 related items for PubMed ID: 26267729

  • 21. Risk of Serious Infection With Biologic and Systemic Treatment of Psoriasis: Results From the Psoriasis Longitudinal Assessment and Registry (PSOLAR).
    Kalb RE, Fiorentino DF, Lebwohl MG, Toole J, Poulin Y, Cohen AD, Goyal K, Fakharzadeh S, Calabro S, Chevrier M, Langholff W, You Y, Leonardi CL.
    JAMA Dermatol; 2015 Sep; 151(9):961-9. PubMed ID: 25970800
    [Abstract] [Full Text] [Related]

  • 22. Cost-effectiveness of secukinumab as first biologic treatment, compared with other biologics, for moderate to severe psoriasis in Germany.
    Augustin M, McBride D, Gilloteau I, O'Neill C, Neidhardt K, Graham CN.
    J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2191-2199. PubMed ID: 29729105
    [Abstract] [Full Text] [Related]

  • 23. Psoriasis in the mature patient: Therapeutic approach in the era of biologics.
    Kostović K, Žužul K, Čeović R, Bukvić Mokos Z.
    Clin Dermatol; 2018 Dec; 36(2):222-230. PubMed ID: 29566926
    [Abstract] [Full Text] [Related]

  • 24. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics.
    Menter A, Strober BE, Kaplan DH, Kivelevitch D, Prater EF, Stoff B, Armstrong AW, Connor C, Cordoro KM, Davis DMR, Elewski BE, Gelfand JM, Gordon KB, Gottlieb AB, Kavanaugh A, Kiselica M, Korman NJ, Kroshinsky D, Lebwohl M, Leonardi CL, Lichten J, Lim HW, Mehta NN, Paller AS, Parra SL, Pathy AL, Rupani RN, Siegel M, Wong EB, Wu JJ, Hariharan V, Elmets CA.
    J Am Acad Dermatol; 2019 Apr; 80(4):1029-1072. PubMed ID: 30772098
    [Abstract] [Full Text] [Related]

  • 25. Effectiveness of sequential use of biologics in the treatment of moderate to severe psoriasis in real world Canadian academic clinical practice: A cohort study.
    Qiang JK, Shahbaz A, Kim W, Marinas J, Greaves S, Yeung J.
    J Am Acad Dermatol; 2016 Jan; 74(1):176-7. PubMed ID: 26702799
    [No Abstract] [Full Text] [Related]

  • 26. Experience With Anti-TNF-α Biologic Agents in Succession in Patients With Crohn's Disease: A Retrospective Analysis of a Single Center.
    Ferges W, Rampertab SD, Shafqet M, Salimi Q, You G, Yousefzadeh E, Cheng JQ, Das KM.
    J Clin Gastroenterol; 2016 Apr; 50(4):326-30. PubMed ID: 25984976
    [Abstract] [Full Text] [Related]

  • 27. Switching of biologics in psoriasis: Reasons and results.
    Honda H, Umezawa Y, Kikuchi S, Yanaba K, Fukuchi O, Ito T, Nobeyama Y, Asahina A, Nakagawa H.
    J Dermatol; 2017 Sep; 44(9):1015-1019. PubMed ID: 28488283
    [Abstract] [Full Text] [Related]

  • 28. Evolving Landscape of Biologic Therapy for Pediatric Psoriasis.
    Do H, Babbush Graber K, Chernoff KA, Melnick LE.
    Dermatol Clin; 2024 Jul; 42(3):377-386. PubMed ID: 38796269
    [Abstract] [Full Text] [Related]

  • 29. Management of psoriasis in patients with inflammatory bowel disease: From the Medical Board of the National Psoriasis Foundation.
    Whitlock SM, Enos CW, Armstrong AW, Gottlieb A, Langley RG, Lebwohl M, Merola JF, Ryan C, Siegel MP, Weinberg JM, Wu JJ, Van Voorhees AS.
    J Am Acad Dermatol; 2018 Feb; 78(2):383-394. PubMed ID: 29332708
    [Abstract] [Full Text] [Related]

  • 30. Comparative effectiveness of less commonly used systemic monotherapies and common combination therapies for moderate to severe psoriasis in the clinical setting.
    Takeshita J, Wang S, Shin DB, Callis Duffin K, Krueger GG, Kalb RE, Weisman JD, Sperber BR, Stierstorfer MB, Brod BA, Schleicher SM, Robertson AD, Linn KA, Shinohara RT, Troxel AB, Van Voorhees AS, Gelfand JM.
    J Am Acad Dermatol; 2014 Dec; 71(6):1167-75. PubMed ID: 25260564
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Adalimumab in the treatment of moderate-to-severe chronic plaque psoriasis in patients switching from other biologics.
    Sator P, Richter L, Saxinger W, Vasiljevic M, Stingl G.
    J Eur Acad Dermatol Venereol; 2015 Sep; 29(9):1742-9. PubMed ID: 25665143
    [Abstract] [Full Text] [Related]

  • 39. Economic evaluation of systemic therapies for moderate to severe psoriasis.
    Sizto S, Bansback N, Feldman SR, Willian MK, Anis AH.
    Br J Dermatol; 2009 Jun; 160(6):1264-72. PubMed ID: 19120346
    [Abstract] [Full Text] [Related]

  • 40. The effect of weight reduction on treatment outcomes in obese patients with psoriasis on biologic therapy: a randomized controlled prospective trial.
    Al-Mutairi N, Nour T.
    Expert Opin Biol Ther; 2014 Jun; 14(6):749-56. PubMed ID: 24661040
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 80.